Fibrin Fiber Stiffness Is Strongly Affected by Fiber Diameter, but Not by Fibrinogen Glycation  by Li, Wei et al.
ArticleFibrin Fiber Stiffness Is Strongly Affected by Fiber
Diameter, but Not by Fibrinogen GlycationWei Li,1 Justin Sigley,1 Marlien Pieters,2 Christine Carlisle Helms,3 Chandrasekaran Nagaswami,4
John W. Weisel,4 and Martin Guthold1,*
1Department of Physics, Wake Forest University, Winston-Salem, North Carolina; 2Centre of Excellence for Nutrition, North-West University,
Potchefstroom, South Africa; 3Department of Physics, University of Richmond, Richmond, Virginia; and 4Department of Cell and
Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, PennsylvaniaABSTRACT The major structural component of a blood clot is a mesh of fibrin fibers. Our goal was to determine whether fibrin-
ogen glycation and fibrin fiber diameter have an effect on the mechanical properties of single fibrin fibers. We used a combined
atomic force microscopy/fluorescence microscopy technique to determine the mechanical properties of individual fibrin fibers
formed from blood plasma. Blood samples were taken from uncontrolled diabetic patients as well as age-, gender-, and
body-mass-index-matched healthy individuals. The patients then underwent treatment to control blood glucose levels before
end blood samples were taken. The fibrinogen glycation of the diabetic patients was reduced from 8.8 to 5.0 mol glucose/
mol fibrinogen, and the healthy individuals had a mean fibrinogen glycation of 4.0 mol glucose/mol fibrinogen. We found that
fibrinogen glycation had no significant systematic effect on single-fiber modulus, extensibility, or stress relaxation times. How-
ever, we did find that the fiber modulus, Y, strongly decreases with increasing fiber diameter, D, as YfD1:6. Thin fibers can be
100 times stiffer than thick fibers. This is unusual because the modulus is a material constant and should not depend on the
sample dimensions (diameter) for homogeneous materials. Our finding, therefore, implies that fibrin fibers do not have a homo-
geneous cross section of uniformly connected protofibrils, as is commonly thought. Instead, the density of protofibril connec-
tions, rPb, strongly decreases with increasing diameter, as rPbfD
1:6. Thin fibers are denser and/or have more strongly
connected protofibrils than thick fibers. This implies that it is easier to dissolve clots that consist of fewer thick fibers than those
that consist of many thin fibers, which is consistent with experimental and clinical observations.INTRODUCTIONIn the event of injury to a blood vessel, platelets aggregate
at the injury site and the clotting cascade is initiated to
form a blood clot that will stop blood flow through the
injured blood vessel. The clotting cascade is a complex se-
ries of protein activations culminating in the activation of
fibrinogen by activated thrombin. Fibrinogen is an abundant
blood protein that consists of a central, globular E region
and two distal D regions that are connected by two triple
a-helical coiled coils (Fig. 1). Thrombin proteolytically
removes two fibrinopeptides A and two fibrinopeptides
B from the N-termini of the a- and b-chains in the central
E region, thereby exposing two knobs ‘‘A’’ (Gly-Pro-Arg)
on the a-chain and then two knobs ‘‘B’’ (Gly-His-Arg) on
the b-chain, and thus converting fibrinogen to fibrin. FibrinSubmitted July 15, 2015, and accepted for publication February 2, 2016.
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creativecommons.org/licenses/by/4.0/).monomers (45 nm long and 4.5 nm thick) bind to each other
in a half-staggered fashion to form double-stranded protofi-
brils. The key interactions for protofibril formation are the
A:a and B:b knob-hole interactions, in which the charged
knobs ‘‘A’’ and knobs ‘‘B’’ bind to holes ‘‘a’’ and holes
‘‘b’’ in the distal D region, and the D:D interactions of abut-
ting D regions (Fig. 1). Protofibrils aggregate laterally (radi-
ally) to form the mature, ~130-nm-thick fibrin fibers of a
blood clot. Lateral aggregation of protofibrils is poorly un-
derstood, but there is evidence that interactions between
the long, largely unstructured a-C regions play a key role
(1,2) in lateral aggregation.
The main physiological function of blood clots, which
mainly consist of platelets and a meshwork of microscopic
fibrin fibers, is to stem the flow of blood. Since this is a
mechanical task, studies have been conducted over the
past 60 years to elucidate the mechanical properties of clots.
The vast majority of these studies were done on whole clots.
For example, rheometry techniques were used to determine
the loss modulus and storage modulus and other mechanical
FIGURE 1 Fibrinfiber assembly. (A) Crystal structure of humanfibrinogen
(42). Fibrinogen has a nearly centrosymmetric structure consisting of two
Aa-chains (yellow, 610 amino acids), two Bb-chains (magenta, 461 amino
acids), and two g-chains (cyan, 411 amino acids). Not resolved in the crystal
structure are residuesa1–26 anda201–610,b1–57 and b459–461, andg1–13
and g395–411. The central E region, which contains the N-termini of all
chains, including fibrinopeptides A (a1–16) and B (b1–14), is connected by
two triple-helical coiled coils to the two distal D regions. The a-C regions
(a221–610), which are drawn in by hand, consist of the unstructured,
61-nm-long aC connector (a221–391; drawn as a yellow line) and the folded
aC domain (a392–610; drawn as two yellow squares). The small blue, red,
and black spheres indicate plasmin lysis sites in the coiled coils; numerous
additional lysis sites (not shown) are in thea-C region. (B) Fibrin interactions.
The half-staggered assembly of fibrin monomers into double-stranded proto-
fibrils ismainlymediated byA:a knob-hole interactions andD:D interface in-
teractions, and to a lesser extent by B:b knob-hole interactions (not shown).
Lateral (radial) assembly of protofibrils into mature fibers is thought to be
mostlymediated by interactions of the a-C regions, resulting in a dense, com-
plex network of a-C regions between protofibrils. For clarity, not all a-C re-
gions are shown in the space betweenprotofibrils. (C) Schematic, longitudinal
cross section of a mature, ~130-nm-wide fibrin fiber, showing a dense fiber
core and a less dense fiber periphery. This decrease in fiber density (or
more specifically, bond density) with increasing fiber diameter is one of the
key findings of this study. The lateral structure is mostly held together by
the network of connected a-C regions (partially shown in B, but for clarity
not shown in C). (D) A false-color scanning electron micrograph of a blood
clot conveys the central role of fibrin fibers in providingmechanical and struc-
tural support to a blood clot. Green, fibrin fibers; purple, platelets; red, red
blood cell (image courtesy ofY. Veklich and J.W.Weisel, University of Penn-
sylvania School of Medicine). To see this figure in color, go online.
Diameter-Dependent Fibrin Stiffnessproperties of clots (3,4), and it was found that these proper-
ties can be associated with thrombotic disease (5–8). In a
clinical setting, thromboelastography is used by clinicians
to uncover clotting abnormalities and to reduce risk in sur-
geries (9,10). In an effort to deepen our understanding of
clot behavior, new techniques, such as atomic force micro-
scopy (AFM) and optical traps, have been developed in
recent years to determine the mechanical properties of sin-
gle fibrin fibers within a fibrin clot (11–13). Single-fiber ex-
periments bridge the gap in scale between whole-clot
experiments and molecular experiments, and the data from
single-fiber experiments are a key building block in con-
structing realistic models of fibrin clots (14). Single-fiber
data are also used to test the predictions of molecular-dy-
namics simulations at the molecular level (15–17).
Most single-fiber investigations have been done on clots
formed from purified fibrinogen, and few data are available
regarding the mechanical properties of individual fibrin
fibers in plasma clots, which are more physiological and
quite different in structure and properties (13). The use of
plasma clots would make it possible to directly measure
the properties of pathophysiological clots from patients
who suffer from specific clotting disorders and diseases.
To our knowledge, the work presented here is the first sin-
gle-fiber study to use plasma clots from patients.
Diabetes is a risk factor for cardiovascular disease
(CVD), increasing CVD risk by 2–4 times (18), and 68%
of morbidity in diabetic patients is due to CVD (19). Ac-
cording to the Centers for Disease Control and Prevention,
diabetes affects 25.8 million people, or 8.3% of the popu-
lation, in the United States (19). The relationship between
CVD and diabetes is not well understood, although alter-
ations to the properties of fibrin clots in diabetic patients
have been reported. Several studies have examined clots
formed from plasma or fibrinogen isolated from diabetic
patients, as well as fibrinogen glycated in the lab, in an
attempt to understand the connections between CVD and
diabetes. However, many of these studies reported conflict-
ing findings, likely as a result of differences in the study
design (e.g., plasma versus purified fibrinogen, and use of
diabetic versus normal plasma with added glucose), study
population, and analytical techniques and methods used.
An important plausible mechanism for altered fibrin net-
works in diabetic patients is nonenzymatic glycation of
fibrinogen in the presence of uncontrolled blood glucose
levels. A few studies reported increased resistance to fibri-
nolysis in samples with increased glycation (18,20). Some
studies showed a shorter lag phase in polymerization and
decreased permeability in diabetic clots (20,21), whereas
a few other studies showed no difference in polymer-
ization, kinetics, clot porosity, and clot density in dia-
betic samples compared with control samples (22,23). No
studies investigating single-fiber properties in clots formed
from the plasma of diabetic patients have been reported
to date.Biophysical Journal 110, 1400–1410, March 29, 2016 1401
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ical properties of individual fibrin fibers formed from
the plasma of diabetic patients and healthy controls.
Our goal was to investigate whether altered fibrin clot
properties in diabetic patients are related to effects of
protein glycation on single-fiber properties. Our results
show that increased glycation does not alter the modulus
or extensibility of single fibrin fibers in a predictable
way. Thus, we conclude that glycation does not have a
direct effect on single-fiber mechanical properties, and
the negative effects of diabetes on cardiovascular health
likely have a different origin than altered single-fiber
mechanical properties.
Because of the large variation in fiber size in our exper-
iments, we also investigated the effect of fiber diameter.
We found that the stiffness (modulus) of fibrin fibers, Y,
strongly decreased with increasing fiber diameter, D, in
all samples. Y scaled as D1.6 over a tested diameter range
of ~20–400 nm, and the thinnest fibers were >100 times
stiffer than the thickest fibers. This is very unusual
behavior since the modulus is a material constant and
does not depend on the dimensions (diameter) of a mate-
rial, assuming the material has a regular, homogeneous
cross section. Our finding, therefore, implies that fibrin
fibers do not have a homogeneous cross section of uni-
formly connected protofibrils, as is commonly thought.
Instead, the density of protofibril connections, rPb, strongly
decreases with increasing diameter, as rPbfD
1:6. Thin fi-
bers are much denser and/or have more densely or strongly
connected protofibrils than thick fibers. We propose, to our
knowledge, a new fibrin fiber model in which fibers are less
densely connected at increasing diameters, resulting in a
lower modulus. We corroborate this model with measure-
ments obtained from individual fibers in plasma fibrin clots
as well as purified fibrin clots.
This finding has several important implications. Although
the assembly of fibrin monomers into protofibrils via A:a
and B:b knob-hole interactions and D:D interface interac-
tions is relatively well understood, the lateral assembly of
protofibrils into mature fibers is poorly understood, and
models for the lateral cross section of a fiber are only spec-
ulative. This lateral assembly is one of the critical pieces
that are still missing from a full understanding of clot for-
mation. Our data provide information about the lateral
cross-sectional organization of fibrin fibers, and therefore
contribute to our understanding of fibrin fiber formation.
Models for fibrin fiber lateral assembly need to be modified
to account for this decreasing lateral density. It is also
important to note that any parameter that affects the radius
of a fiber, such as the fibrinogen or thrombin concentration,
will strongly affect the modulus of the fiber and thus the
entire clot. Thin fibers are denser than thick fibers, and
thick fibers likely have a denser core and a less dense
periphery. Thus, thin fibers and the core of thick fibers
are likely harder to dissolve. This key finding may explain1402 Biophysical Journal 110, 1400–1410, March 29, 2016the clinically found relationship between thin fibers and
increased risk of thrombotic diseases, in particular,
myocardial infarction, ischemic stroke, and venous throm-
boembolism (7).MATERIALS AND METHODS
Plasma collection and determination of
fibrinogen concentration and glycation
We investigated the fibrin fibers of plasma clots formed from 14 different
plasma samples and obtained ~15 measurements per sample for all exper-
iments. The samples included four control (nondiabetic) individuals, five
controlled diabetic patients, and five noncontrolled diabetic patients. Blood
was collected from the diabetic patients both before intervention (uncon-
trolled diabetics) and after intervention (controlled diabetics). Several clots
were formed from the same plasma samples over the duration of the study.
We did not observe any significant difference in the viscoelastic properties
of fibers from the same plasma sample over the course of the investigation.
All of the plasma samples were collected from black females between the
ages of 44 and 65, with a median age of 58. To limit the number of vari-
ables, we did not include males.
To determinewhether glycation had an effect on themechanical properties
of single fibrin fibers, we recruited 20 type 2 diabetic and 18 nondiabetic in-
dividuals (control) (20,23). From this group, we used the subset of 14 sam-
ples mentioned above for single-fiber studies. Patients had to be
uncontrolled (HbA1C> 9%) on maximum-dose combination oral hypogly-
cemic medication, have a body mass index (BMI) of >25 kg/m2, be 40–65
years of age, and have sufficiently controlled blood pressure (<140/90 mm
Hg) to be included in the study. After baseline blood samples were collected,
the patients underwent a three-step intervention program. First, the patients
were taught how tomonitorglucose levels, coordinate insulin usewithmeals,
and manage hypoglycemic events with glucagon. Second, the patients
received 10 IU (equivalent to 0.347mg) of insulin daily in addition to the cur-
rent treatment of maximum-dose oral hypoglycemic treatment. Metformin
use was unchanged, sulphonylureas were stopped, and insulin use was
adjusted individually until four out of five subsequent fasting blood glucose
values were<7.2 mM. Lastly, short-acting insulin was used to control post-
prandial glucose levels (<10 mM). Once both fasting and postprandial gly-
cemic control were achieved, the subjects remained on treatment for 8 days
before end blood samples were collected. Nondiabetic control subjects with
matching age, gender, and BMI were included. Baseline oral glucose toler-
ance tests were done to rule out diabetes in the controls. Citrated blood
was collected from patients. Within 30 min of collection, the blood was
centrifuged for 15 min at 2000 g at 4C. The plasma was extracted, snap-
frozen, and stored at 80C until fiber samples were prepared.Fibrinogen concentration
Fibrinogen concentration was measured as previously described in (23)
using a modified Clauss method on an Automated Coagulation Laboratory
200 (Instrumentation Laboratories, Milan, Italy; between-run coefficient of
variation (CV) ¼ 3%). Fibrinogen was purified from the plasma of each
subject by IF-1 affinity chromatography as described in (24). Purified fibrin-
ogen was run on 10% SDS-PAGE gels to confirm purity and the absence of
degradation of the fibrinogen preparations (see Fig. 1 in (23)).Fibrinogen glycation
Fibrinogen glycation was measured as previously described (23) using a
two-reagent enzymatic assay (GlyPro assay, Genzyme Diagnostics, Cam-
bridge, MA; between-run CV ¼ 5%). This is a specific enzymatic method
for the direct measurement of glycated proteins in serum or plasma. The
Diameter-Dependent Fibrin Stiffnessfirst reagent digests the proteins and subsequently releases glycated protein
fragments. Ketoamine oxidase in the second reagent facilitates the specific
oxidation of the ketoamine bond of the glycated protein fragment substrate.
Liberation of hydrogen peroxide allows a colorimetric determination of the
amount of glycated protein in an end-point reaction. Absorbance at 550 nm
was measured after the addition of reagent 1 and again after reagent 2.
Results were calculated as follows: glycated protein (mM) ¼ ((DAsample)/
(DAcalibrator))  calibrator value (mM).Substrate preparation
Striated cover slides were prepared as previously described (11,12). Briefly,
optical adhesive (NOA-81, Norland Products, Cranbury, NJ) was placed on
a cover slide. A rectangular polydimethylsiloxane stamp was pressed into
the adhesive to create a 1.5 cm  1.5 cm wide and 0.5 cm deep well to
hold the buffer. In the center of the well, a drop of optical glue was placed
and a second polydimethylsiloxane stamp was used to create a striated sur-
face with 6.5 mm wide ridges, and 13.5 mm wide and 6.0 mm deep grooves.
The optical glue was then cured under 365 nm UV light (3UV transillumi-
nator, UVP, Upland, CA) for 1.5 min.Fibrin sample preparation
All chemicals were obtained fromSigma-Aldrich unless otherwise noted. To
form fibrin fibers, an 18 mL aliquot of plasma solution (14 mL of citrated
plasma and 4 mL of 0.1 M CaCl2) was combined with 2 mL of thrombin
(Enzyme Research Laboratories, South Bend, IN; final concentration
0.1 NIH units/mL) and pipetted onto the striated cover slide. The clotting re-
action ran for 1 h in a moist atmosphere at room temperature. This time
period was chosen to allow completion of fiber formation, including stabili-
zation of fibrin by factor XIIIa. After an hour, the slide was rinsed with cal-
cium-free buffer (140 mM NaCl, 10 mM Hepes, pH 7.4). A pipette tip was
used to manually remove excess fibers from the top of the sample. The sam-
ple was then rinsed with fibrin buffer (140 mM NaCl, 10 mM Hepes, 5 mM
CaCl2, pH 7.4). The fibers were labeled with 20 nm carboxyl-coated fluoro-
spheres (Invitrogen, Carlsbad, CA) and rinsed with fibrin buffer once again.
Purified fibrin samples were formed in a manner similar to that used
for the plasma fibrin samples. In this case, a 2 mL mixture of thrombin
(final concentration 0.3 NIH units/mL) and FXIII (Enzyme Research
Laboratories, South Bend, IN; final concentration 9 Loewy units/mL) was
added to 18 mL of purified fibrinogen in concentrations varying from
0.8 mg/mL to 6 mg/mL. After clotting, the mixtures were rinsed with
calcium-free buffer and labeled with 20 nm fluorospheres.Manipulations
Fibrin clots were visualized with an inverted fluorescence microscope
(Fig. 2). Straight fibers that spanned a groove and had no branchpointswithin
that span were chosen for manipulation. The groove width corresponds
approximately to the length between branch points in a plasma fibrin clot
(5,13). Fiber modulus, extensibility, and stress relaxation behavior were
determined as previously described (11); for details, see Supporting Mate-
rials andMethods in theSupportingMaterial.Manipulationswere performed
using a combined AFM (Topometrix Explorer, Veeco Instruments, Wood-
bury, NY) and inverted fluorescence microscope (Axiovert 200 or Observer
D, Zeiss, Go¨ttingen, Germany). The fiber sample was placed between the
AFM and optical microscope using a customized stage that allowed the
sample to be moved independently of either microscope. Illumination of
the samplewas provided by a camera light in theAFM. Fiberswere stretched
with the AFM probe (CSC-38, MikroMash, Willsonville, OR) at a rate of
~320 nm/s. Cantilever deflection, distance, and time data were collected
with the use of NanoManipulator software (3rd Tech, Chapel Hill, NC). Im-
ages were collected during manipulations using a Zeiss AxioCam and Zeiss
Axiovert software, or a Hamamatsu EM-CCD C9100 camera (Hamamatsu
Photonics, KK, Japan) with IPLab software (Scanalytics, Fairfax, VA). Fiber
diameter, D, was determined by using the AFM to image the fiber on top of
the ridge, adjacent towhere the fiberwasmanipulated.The fiber cross section
was calculated assuming a circular cross section, A ¼ pðD=2Þ2.
Extensibility
In an extensibility measurement, a fiber is simply stretched until it breaks,
and the strain at the breaking point, εmax¼DLmax/Linital, is termed the exten-
sibility. Strain is defined as ε¼DL/Linital, withDL¼L’Linitial, whereLinitial
is the initial length of the fiber and L’ is the extended length of the fiber.
Stiffness (stretch modulus) and relaxation times
We used incremental stress-strain (force-extension) curves to determine
the longitudinal stiffness (modulus) and stress relaxation times of fibrin
fibers.
In a simple stress-strain curve, a force, F, is applied longitudinally to an
elastic fiber with cross-sectional area, A, causing a strain, ε. The stretch
modulus, Y, is the proportionality constant between the applied stress,
s¼ F/A, and the resulting strain, ε: s¼ Y ε. An example of an incremen-
tal stress-strain curve is shown in Fig. S1. In these measurements, the fiber
is stretched and then held at a constant strain for a period of time before be-
ing stretched again. The process is repeated at higher and higher strains.
The slope of the unrelaxed stress-strain curve corresponds to the total
stretch modulus (total stiffness), and the slope of the relaxed stress-strainFIGURE 2 Fibrin fiber manipulation. (A) Sche-
matic of fibrin fiber manipulation. The fiber is sus-
pended over the grooves in a striated substrate. The
AFM tip, located above the sample, pulls on the
fiber while the optical microscope, located below
the sample, acquires images and movies of the
manipulation. (B) Top view schematic of fiber
manipulation. Linitial is half the initial length of
the fiber, L0 is half the length of the stretched fiber,
and s is the distance the tip has traveled. L0 can be
found trigonometrically from Linitial and s, and the
strain can be calculated from these quantities (see
text). Schematics (A) and (B) were adapted from
(11). (C) Optical microscopy movie frames of a fi-
ber being stretched and broken. The movie was re-
corded from underneath the sample. The large dark
object (rectangle plus triangle shape) is the AFM
cantilever and the AFM tip is marked by an
asterisk. The fiber broke at a strain of 200%. Scale
bar, 10 mm. To see this figure in color, go online.
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Li et al.curve corresponds to the elastic component of the total modulus. We found
that the elastic modulus is typically a factor of ~0.6 lower than the total
modulus, and for simplicity, we will only report the total modulus here
(for the elastic modulus, see Supporting Materials and Methods). When
the fiber is held at constant strain, the stress decays (see Supporting Mate-
rials and Methods). This is indicative of viscoelastic behavior. The simplest
mechanical model that can account for these observations (the two relaxa-
tion rates; stress does not decay to zero) is a generalized Kelvin model con-
sisting of an elastic spring with modulus YN, in parallel with two Maxwell
elements consisting of a dashpot and a spring in series (11). For this model,
the equation for stress relaxation becomes
sðtÞ ¼ ε0

YN þ Y1  et=t1 þ Y2  et=t2

; (1)
where YN is the relaxed elastic modulus and Y is the total elastic modulus,
Y ¼ YN þY1 þ Y2. By fitting an exponential curve to the stress decay, we
can determine key mechanical properties (i.e., the total modulus, elastic
modulus, and relaxation times) of the fibers (11). A double exponential
(two relaxation times) is required to obtain good fits (see Supporting Mate-
rials and Methods for a comparison between a single exponential and a dou-
ble exponential). Thus, applying this Kelvin model to fibrin fibers yields
several parameters. Y1 and Y2, which are the spring constants of spring
1 and spring 2, can be obtained from the fits. Additionally, the relaxation
times t1 and t2 can also be obtained from the fits. Moreover, the relaxation
times, the elastic modulus of the springs, and the viscosity of the dashpot
elements are related via t1 ¼ m1/Y1 and t2 ¼ m2/Y2, and therefore the vis-
cosities m1 and m2 of the dashpots can also be extracted from our data.
The total modulus, Y, and the extensibility εmax are reported in the main
text since they are model independent, and YN (also model independent)
and Y1, Y2, t1, t2, m1, and m2 (all model dependent) are reported in Support-
ing Materials and Methods. We refrained from assigning any of the ele-
ments in the Kelvin model to actual structural elements in single fibers
because that would be too speculative. Such assignments would require
modifying some structural elements in the actual fibrin fiber (e.g., removing
the a-C region or other bonds) and then testing the effect on the fibrin fiber
mechanical properties.Statistical analysis
Means and standard deviations were calculated using standard equations.
To determine statistical significance between samples, a two-tailed t-test
was used with an a-level set at 0.05. Linear and monotonic relationships
between two variables were tested using Pearson’s correlation and Spear-
man’s correlation. Detailed results of the statistical analysis are reported
in Supporting Materials and Methods.RESULTS
Fiber viscoelastic properties
Fibrin fibers of plasma clots from 14 different plasma
samples, as detailed in the Materials and Methods section,
were investigated. The blood fibrinogen concentration in
the four control and five diabetic patients ranged from 3.5
to 5.6 mg/mL. Fibrinogen glycation ranged from 3.0 to
11.8 mol glucose/mol fibrinogen. Before intervention, the
uncontrolled diabetic patients had an average fibrinogen
glycation of 8.8 5 3.4 mol glucose/mol fibrinogen, which
decreased to an average of 5.0 5 2.4 after intervention.
The glycation of all diabetic patients decreased after inter-
vention. The nondiabetic control group had an average
fibrinogen glycation of 4.0 5 1.0.1404 Biophysical Journal 110, 1400–1410, March 29, 2016We determined several key mechanical properties of
plasma fibrin fibers (extensibility, total modulus, and stress
relaxation times (main text), and elastic modulus and vis-
cosities (Supporting Materials and Methods)) as a function
of glycation, fibrinogen concentration, and fiber diameter.
Glycation
Fiber extensibility for the various plasma samples from dia-
betic and control subjects varied from 1.2 to 2.7, largely in
agreement with previously reported values for purified
fibrinogen samples (11,12). There was no clear trend in
a plot of extensibility versus glycation (Fig. 3 A). The total
modulus of the fibrin fibers varied from 1.0 MPa to 28 MPa
(Fig. 3 C). Since the modulus of fibrin fibers varies strongly
with fiber diameter as Y(D) ¼ Y0  D1.6 (see below,
Fig. 5 A), to properly compare the moduli of different fiber
samples with each other, we had to adjust the modulus for
this diameter dependence. Therefore, we calculated a
diameter-normalized modulus, Yn130, for each fiber sample.
We first multiplied each individual fiber data point by
Dþ1.6 to determine Y0, and then we multiplied this value
by 1301.6 because the average fiber in each group was
130 nm (Fig. S4). We averaged these values to obtain
the diameter-normalized, average modulus for a standard
130 nm fiber, Yn130, for each sample. When we plotted the
normalized modulus, Yn130, versus glycation, we again
observed no apparent trend (Fig. 3 D). When we measured
stress decay, we found that the fibers had an average fast
relaxation time of t1 ¼ 2.3 s and an average slow relaxation
time of t2 ¼ 34 s (Fig. 3 B). t1 and t2 also did not show a
dependence on glycation. In a related published work
(20), it was shown that glycation did not seem to affect
the diameter distribution of fibrin fibers, other than a slightly
higher fraction of larger fibers in the end-point diabetic sam-
ple (after glycemic control). Therefore, it is also unlikely
that glycation would indirectly affect single fibrin fiber
mechanical properties through a change in diameter. In sum-
mary, glycation does not seem to have an effect on the
mechanical properties of single fibrin fibers (Fig. 3).
Fibrinogen concentration
Numerous clinical and epidemiological studies have indi-
cated that an elevated fibrinogen concentration may be a
risk factor for CVD (25). Using our plasma samples, we
also tested whether fibrinogen concentration (in our avail-
able range from 3.5 mg/mL to 5.6 mg/mL) had an effect
on single fibrin fiber properties. All of our samples had
relatively high fibrinogen concentrations, consistent with
studies that reported higher fibrinogen levels in black Afri-
can and African-American individuals as compared with the
range of 1.5–3 mg/mL typically found in healthy white
individuals (26,27). Fibrinogen concentration did not have
a consistent, systematic effect on fibrin fiber extensibility,
relaxation time, modulus, or diameter-normalized modulus
(Fig. 4, A–D) at the concentrations we tested.
FIGURE 3 Fibrin fiber mechanical properties
as a function of glycation. (A) Extensibility. (B)
Fast and slow stress relaxation times. (C) Total
modulus. (D) Diameter-normalized total modulus
for an average 130 nm fibrin fiber. No significant,
systematic trend is observed between these me-
chanical properties and glycation. Error bars are
standard error of the mean.
Diameter-Dependent Fibrin StiffnessFiber diameter
Experimental and clinical evidence indicates that fibrin clots
composed of highly branched networks with thin fibers are
associated with thrombotic disease (5–8). However, the
underlying reason for this association is not known. There-
fore, we decided to also investigate the direct effect of fiber
diameter on the fiber modulus. Fig. 5 shows the results
of this analysis: the fiber modulus strongly decreases with
increasing radius for all plasma samples and for samplesformed from purified fibrinogen. There is a significant
(p< 0.01) negative power law relationship between the fiber
modulus and fiber diameter (notice the log scaling). The
exponent for plasma fibrinogen fibers is 1.6 (N ¼ 213,
R2 ¼ 0.26), whereas the exponent for purified fibrin fibers
is 1.4 (N ¼ 116, R2 ¼ 0.17); that is, the modulus, Y,
depends on the diameter, D, as YfD1:6 (plasma) and as
YfD1:4 (purified fibrinogen). Thus, two plasma fibers
with different diameters, D1 and D2, would have a different
modulus by a factor of (D1/D2)
1.6. This is very unusualFIGURE 4 Fibrin fiber properties as a function
of fibrinogen concentration. (A) Extensibility. (B)
Fast and slow stress relaxation time. (C) Total
modulus. (D) Diameter-normalized total modulus
for an average 130 nm fibrin fiber. No significant,
systematic trend is observed between these me-
chanical properties and fibrinogen concentration.
Error bars are standard error of the mean.
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FIGURE 5 Fibrin fiber modulus as a function of
fiber diameter. (A and B) Log-log plot of the total
stretch modulus as a function of diameter for
plasma samples (A) and purified fibrinogen sam-
ples (B). The modulus strongly depends on the fi-
ber diameter, as YfD1:6 (plasma) and YfD1:4
(purified fibrinogen).
Li et al.since the modulus is a material property and should not
depend on fiber dimensions. As explained in more detail
in the Discussion, our data imply that fibrin fibers do not
have a homogeneous cross section, since for a homogeneous
cross section the modulus would be independent of the
diameter.DISCUSSION
We set out to measure the mechanical properties of single
fibrin fibers in clots formed from the plasma of diabetic
patients to determine whether fibrinogen glycation has an
effect on fiber mechanical properties. Our work resulted
in three major overall findings. 1) Our combined AFM/
inverted optical microscopy technique is suitable for testing
complex plasma samples, in addition to the samples formed
from purified fibrinogen that have been tested in the past.
This opens up the possibility of investigating the properties
of single fibrin fibers from many different patient samples.
2) We found that there was no significant direct correlation
between fibrinogen glycation and fibrin fiber extensibility,
modulus, and stress relaxation, as tested using Pearson’s
correlation and Spearman’s correlation (for details, see Sup-
porting Materials and Methods). Thus, the known clinical
correlation between diabetes and CVD is likely not due to
altered mechanical properties of fibrin fibers as a result of
hyperglycated fibrinogen. 3) The diameter of the fibrin
fibers ranged from ~20 nm to 400 nm; therefore, we also
investigated the effect of diameter on single fibrin fiber me-
chanical properties. We observed a strong negative power
law relationship between the fiber modulus, Y, and fiber
diameter, D: Y scales as D1.6 (plasma samples) and D1.4
(purified fibrinogen). The strong dependence of the modulus
on fiber diameter is very unusual and has interesting and sig-
nificant consequences for whole-clot properties, and espe-
cially for the internal structure and lateral assembly of
fibrin fibers, as discussed in the next paragraphs.Whole-clot modulus
Because thin fibers are stiffer, whole clots composed of
many thin fibers would have a higher modulus than clots
composed of fewer thick fibers, at similar fibrinogen con-1406 Biophysical Journal 110, 1400–1410, March 29, 2016centrations. In a study performed with near-physiological
fibrinogen concentrations (ranging from ~1 mg/mL to
8 mg/mL), clots that formed at higher thrombin concentra-
tions were shown to have thinner fibers (and more branch
points) (4). And, indeed, the whole-clot modulus was also
shown to increase in these clots with thinner fibers (4).
This increase has generally been attributed to the increased
density of branch points observed in clots with small-diam-
eter fibers. However, in this study, we also observed an
increased fiber modulus as fiber diameter decreased, in
the absence of branch points. Thus, the increased modulus
of clots formed from thinner fibers might be due to an
increased modulus of the single fibers that make up the
clot, as well as to increased branch points.Internal fibrin fiber structure and lateral fiber
assembly
The stretch modulus is a material property that is used
to define the stiffness of a material under tensile stress.
The modulus does not depend on the dimensions of the
material (e.g., fiber diameter), provided that the material
composition is homogeneous. In our fiber context, ‘‘homo-
geneous’’ means that the fiber would have a uniform density
of equally connected protofibrils in the radial direction
(Fig. 6 A). Our observation that the modulus of fibrin fibers
depends on the diameter implies that fibrin fibers do not
have a homogeneous cross-sectional composition. Thus,
we propose, to our knowledge, a new model in which the
density of the protofibrils and/or the protofibril connections
within a fiber varies with diameter (Fig. 6). It is important
to note that since we measure the strength of a fiber, we
can draw conclusions about the density of the bonds that
connect the protofibrils together, not just the density of the
protofibrils.
From a mechanics of materials point of view, the Young’s
modulus is proportional to the density and strength of the
bonds that connect the material subunits in the longitudinal
direction. For fibrin fibers, these are the bonds that connect
protofibrils to each other. Since fibers grow simultaneously
in the longitudinal and lateral directions to form a mature
fiber, protofibrils need to assemble in a staggered fashion
to form a mature fiber (28). This means that the lateral bonds
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FIGURE 6 Fibrin fiber models and their corresponding stretch modulus.
(A) A fiber with a cross section of uniformly connected protofibrils will
have a stretch modulus that is independent of diameter, D. (B) A fiber
with a bicycle-spokes-like cross section will have a stretch modulus that de-
creases as D1. (C) In our experiments, the stretch modulus scales as D1.6,
indicative of a cross section in which the density of connected protofibrils
likewise decreases strongly with increasingD, asD1.6. To see this figure in
color, go online.
Diameter-Dependent Fibrin Stiffnessbetween protofibrils also provide longitudinal strength. The
key bonds that connect protofibrils are most likely the bonds
within the network of a-C regions (1,2) (Fig. 1 B).
As indicated in Fig. 1, we assume that fibrin fibers consist
of an array of longitudinally arranged, ribbon-shaped pro-
tofibrils (28). In such an array, we further assume that pro-
tofibrils are connected with each other such that the force
required to stretch a fibrin fiber is proportional to the number
of bonds connecting the protofibrils. For a cross section in
which the protofibrils are evenly distributed, the number
of protofibril bonds, NPb, increases proportionally to the
cross-sectional area (A ¼ (p/4)D2 for a circular cross sec-
tion) and thus to D2. The force to stretch a fiber, F(D),
increases as D2, and the Young’s modulus would be inde-
pendent of D (Fig. 6 A). The cross-sectional protofibril
bond density, rPb¼ NPb/A, would be constant, i.e., indepen-
dent of D. Using similar arguments, if we assume that a
fibrin fiber forms a bicycle-spokes-like structure of protofi-
brils, the number of protofibril bonds per cross section, NPb,
would increase linearly with diameter. Thus, the stretching
force required to reach a specific strain would also increase
linearly as a function of the radius, FðDÞfD; the protofibril
bond density, rPb, would vary as 1/D; and the Young’s
modulus would also vary as 1/D (Fig. 6 B). In our experi-
ments, the Young’s modulus decreased even more strongly
with diameter, as D1.6. To explain these data, we propose
a model in which the protofibril bond density, rPb, alsovaries asD1.6 (Fig. 6 C). In this model, the fiber has a dense
core of well-connected protofibrils that becomes less dense
as more protofibrils aggregate onto the outside of the fiber.
The longitudinal cross section of such a structure is shown
in Fig. 1 C. It may seem that the structure in Fig. 6 C is
not stable, since protofibrils are missing at the periphery.
However, it should be kept in mind that the unstructured
a-C connector, which is part of the network of connected
a-C domains, is 61 nm long and thus could bridge distances
of tens of nanometers between inner and outer protofibrils.
These connections are not shown in Fig. 6 C, but are sche-
matically shown in Fig. 1 B. It should also be kept in mind
that protofibrils are typically a few hundred nanometers long
in the longitudinal direction, which means that they can
form many lateral (radial) connections along their length.
We will now discuss this model in the context of Yang
et al.’s (28) multibundle model, which is based on protein-
protein contacts as seen in various fibrinogen crystals,
and some recent diffraction, scattering, and imaging exper-
iments that probed the internal structure of fibrin fibers.
Yang et al. proposed that fibrin monomers assemble into
wavy protofibril ribbons via the known and well-accepted
A:a, B:b, and D:D interactions. Protofibrils then assemble
via lateral associations between g-chains and b-chains
into mature fibers. It is likely that the largely unstructured
a-C regions also play a critical role in the lateral assembly
of protofibrils (1,29). The protofibrils are staggered in the
x and y (lateral) and z (longitudinal) directions. This stagger
along all three axes is required so that fibers can grow in the
lateral and longitudinal directions simultaneously. The mul-
tibundle model results in a regular crystalline fiber assembly
with unit cell dimensions of 19 nm  19 nm in the lateral
(radial) dimension and 46 nm in the longitudinal dimen-
sion. Peaks corresponding to these unit cell dimensions
have been observed in energy dispersive x-ray diffraction
(30) and small-angle x-ray scattering (SAXS) experiments
(31). However, the peaks corresponding to the lateral peri-
odicity (19 nm) were broad and weak (31), indicating only
weak ordering in the lateral (radial) direction. Moreover,
AFM images suggest that the 22.5 nm periodicity (corre-
sponding to the half-staggered arrangement of the 45 nm
fibrin monomer in the longitudinal direction) disappears
as fibers increase in diameter (32). SAXS and light-scat-
tering data point to a fiber with a protein content of only
15% and a very porous cross section that becomes increas-
ingly porous as the diameter increases (31). AFM rupture-
force experiments on dry fibers also suggest a fiber cross
section that becomes increasingly porous with increasing
diameter (33). All of these experiments suggest a loose,
open, and only weakly crystalline fiber internal structure.
Some studies suggest that the density of protofibrils may
decrease with increasing radius (31–33).
Our experiments probed the density and/or strength
of the connections between protofibrils, and the results
constitute direct evidence that the connections betweenBiophysical Journal 110, 1400–1410, March 29, 2016 1407
Li et al.protofibrils become fewer and/or weaker as the fiber diam-
eter increases. In all of our plasma fibers, the density/
strength of the protofibril connections decreased as approx-
imately D1.6 (Fig. 6 C). The underlying structural reason
for this decreasing density or strength of connections be-
tween protofibrils could be 1) a decrease in the actual pro-
tein/protofibril density with increasing diameter, 2)
a decrease in the number of connections between protofi-
brils with increasing diameter, 3) a decrease in the strength
of connections between protofibrils with increasing diam-
eter, or 4) a combination of these factors. To distinguish
among these four possibilities, additional experiments
that could quantitatively determine the actual protein/pro-
tofibril density as a function of fiber diameter would be
needed. Possible techniques to use for such experiments
could include electron microscopy of fiber cross sections,
turbidity (light scattering) or SAXS experiments on fibrin
clots, and fluorescence intensity measurements on single fi-
bers. Electron microscopy could provide images of a fiber
cross section (33); however, this technique has the draw-
back that fibers shrink as they are processed for and imaged
in an electron microscope (34). Turbidity and SAXS exper-
iments on fibrin clots indicate that larger fibers do have
lower protein density (31). However, it may be difficult
to extract accurate, quantitative values for the protein den-
sity in single fibers. A combined AFM/fluorescence micro-
scope could be used to determine the fluorescence intensity
of fluorescently labeled fibers as a function of diameter
(33). The AFM is required to determine the diameter of
the fibers, since the fibrin fiber diameter is below the reso-
lution limit of optical microscopy. Such measurements
could provide a trend of fluorescence, which scales with
protein density, versus fiber diameter (33).Implications for fiber assembly
It is not yet clear what mechanisms might restrict bond for-
mation between protofibrils and restrict protofibril aggrega-
tion as fibers grow thicker. One possible mechanism is
twisting, which increases the path length and stretching of
protofibrils in thicker fibers, i.e., protofibrils lose registry
due a changed binding geometry as the fiber diameter in-
creases (35). Another mechanism that would also be consis-
tent with our data is activation- or diffusion-limited
aggregation (36) of fibrin fibers from protofibrils. Recent
work on whole clots found that incipient clots have a fractal
dimension of 1.7 (37), and the authors suggested that clots
may assemble via activation-limited aggregation of clusters
of rod-like particles (38). When applied to the assembly
of single fibers, these activation- or diffusion-limited aggre-
gation mechanisms would result in a fractal fiber cross
section in which the protofibril density would decrease
with increasing diameter, as we have observed experimen-
tally. In the context of a fiber cross section, the fractal
dimension, F, is the exponent in the relationship between1408 Biophysical Journal 110, 1400–1410, March 29, 2016the number of protofibrils, N, and the diameter of the fiber,
D: N ¼ DF. For a solid, homogeneous cross section (Fig. 6
A), F would be 2. For purely diffusion-limited aggregation,
F would be ~1.7, i.e., the fiber’s protein content would
decrease as its diameter increased. For activation- and diffu-
sion-limited aggregation, F would be less than that. In our
data (Fig. 6 C), the bond density, rPb, scales as D
1.6, and
thus the number of bonds per cross section, Npb, would scale
as D–1.6 þ 2 ¼ D0.4. Npb ¼ r  A, where A is the cross-
sectional area of the fiber, A ¼ p  (D/2)2. Thus, our data
suggest that fibrin fibers have a very low fractal dimension
of 0.4 for the number of bonds in a fibrin fiber cross section.
Our data suggest that fibrin fibers start out with a well-con-
nected semicrystalline core of protofibrils, but then the fiber
becomes increasingly porous and disorganized as more pro-
tofibrils aggregate. This increased disorganization may be
consistent with the out-of-registry assembly model (35)
and the recently proposed early-branching model (39).Clinical implications and fibrinolysis
There is increasing experimental and clinical evidence that
fibrin clots composed of highly branched networks with
thin fibers are associated with thrombosis, in particular
myocardial infarction, ischemic stroke, and venous throm-
boembolism (5–8). There is also experimental evidence
that clots with thinner fibers lyse more slowly than clots
with thick fibers, even when normalized for total fibrinogen
concentration (40). Our model provides a simple explana-
tion for the slower lysis of clots composed of thin fibers:
thin fibers have a higher bond density than thick fibers
and thus are harder to lyse.Blood clot modeling
Modeling of whole clots can help to reveal correlations
among clot mechanical properties, diseases, and treatment.
It should be possible to calculate the bulkmechanical proper-
ties of a whole fibrin clot by knowing the properties of the
individual components. Our single-fiber data provide the
foundation for determining initial parameters for modeling
whole fibrin clots. A distinct advantage ofmodelingwith cor-
rect single-fiber properties is that it enables one to determine
the differences in themechanical properties of networks with
very dissimilar structures. Our results demonstrate why it is
important tomeasure the properties of different types of indi-
vidual fibers before incorporating them into a model.
In previous work, we reported the average modulus of
fibrin fibers (11,41) and did not take the currently observed
diameter dependence of the modulus into account. This
means that the modulus of thin fibers was underestimated
and the modulus of thick fibers was overestimated. Typi-
cally, the diameter of the previously examined fibers was
on the order of 100–160 nm, and the over- and underesti-
mates approximately balanced out. Differences observed
Diameter-Dependent Fibrin Stiffnessin comparing two types of fibers, e.g., cross-linked and un-
cross-linked fibers, will still hold up if the diameter distribu-
tion of the samples is approximately the same. This was the
case in all of our work. The diameter dependence of the
modulus will have the biggest impact for samples that are
made up of thinner or thicker than normal fibers.CONCLUSIONS
Using plasma samples from uncontrolled and controlled
diabetic individuals and a nondiabetic control group, we
determined that glycation does not seem to have an effect
on single fibrin fiber mechanical properties. This implies
that the observed epidemiological correlation between dia-
betes and CVD likely does not have a molecular origin at
the single fibrin fiber level.
Using these plasma samples and samples prepared frompu-
rified fibrinogen, we observed a strong dependence of fibrin
fiber modulus on fiber diameter, D: the modulus decreases
as D1.6. This observation can be best explained with a new
fibrin fiber model in which the cross-sectional density of
bonds within fibrin fibers decreases with increasing diameter;
that is, fibrin fibers become less densely connected as their
diameter increases. Such amodel is not consistentwith a crys-
talline, homogeneous cross section of equally connected pro-
tofibrils, where the modulus would be independent of D.
Our findings imply that any parameter that affects the
diameter of fibrin fibers, such as the thrombin concentration,
will have a strong effect on the modulus of single fibers. This
in turn will have a strong effect on whole-clot mechanical
properties and, presumably, the in vivo behavior of blood
clots. Clinically, our model provides a simple explanation
for the observation that clots composed of thin fibers are
harder to lyse: thin fibers have a higher bond density than
thick fibers. In addition, in clot dissolution, lytic factors
(e.g., plasminogen) and plasminogen activators (e.g., tPA,
urokinase, and streptokinase) need to reach the inside of clots
and fibrin fibers (see plasmin cleavage sites in Fig. 1 A). Our
model, in which thinner fibers are denser than thick fibers,
implies that it should be easier to dissolve clots that consist
of fewer thick fibers than those that consist of many thin fi-
bers, which is consistent with experimental (40) and clinical
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